Vorinostat Terminated Phase 2 Trials for Follicular Lymphoma (FL) / Mantle Cell Lymphoma (MCL) / Marginal Zone Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
NCT01500538A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)